Enhancing Care With Noninvasive Liver Disease Assessment: New Guidelines (Medscape)

Chronic liver disease (CLD) often progresses silently, making early identification of at-risk patients crucial. Traditionally, liver biopsies were used for staging, but noninvasive liver disease assessments (NILDA) are becoming the norm. The American Association for the Study of Liver Diseases (AASLD) has released new guidelines to help clinicians incorporate NILDA, particularly blood-based models, into practice. These guidelines emphasize the importance of understanding and correctly applying these tests, which offer a less invasive and potentially more accurate alternative to biopsies in managing CLD.